Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignancies Multiple”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07192588
What this trial is testing

GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer

Who this might be right for
Radiodermatitis; Acute
Graegis Pharmaceuticals Ltd 273
Not applicableNo Longer AvailableNCT00720603
What this trial is testing

This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma
Genzyme, a Sanofi Company
Large-scale testing (Phase 3)UnknownNCT02387086
What this trial is testing

Gefitinib Combined With Thalidomide to Treat NSCLC

Who this might be right for
NSCLC
Bai Jun 380
Not applicableActive Not RecruitingNCT05388370
What this trial is testing

PASS of Paediatric Patients Initiating Selumetinib

Who this might be right for
Neurofibromatosis Type 1
AstraZeneca 124
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06744894
What this trial is testing

SIL as Maintenance Therapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Navy General Hospital, Beijing 50
Testing effectiveness (Phase 2)Study completedNCT01753453
What this trial is testing

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

Who this might be right for
Multiple Myeloma
Sanofi 23
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Not applicableStudy completedNCT03317483
What this trial is testing

DEB-TACE Treatment in 367 Liver Cancer Patients

Who this might be right for
Liver Cancer
Zhejiang Cancer Hospital 367
Early research (Phase 1)Ended earlyNCT04679194
What this trial is testing

Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT

Who this might be right for
AML/MDS
Mana Therapeutics 11
Early research (Phase 1)Not Yet RecruitingNCT06647329
What this trial is testing

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

Who this might be right for
CAR-T Cell TherapyLymphomas
Mingzhi Zhang 30
Testing effectiveness (Phase 2)Study completedNCT05577702
What this trial is testing

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 121
Large-scale testing (Phase 3)Looking for participantsNCT05956639
What this trial is testing

Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
The First Affiliated Hospital with Nanjing Medical University 100
Not applicableStudy completedNCT02692339
What this trial is testing

Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 22
Early research (Phase 1)Not Yet RecruitingNCT07660939
What this trial is testing

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

Who this might be right for
Plasma Cell DisordersMultiple Myeloma (MM)
Peking University First Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01826045
What this trial is testing

Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical Intraepithelial Neoplasia
BioLeaders Corporation 200
Not applicableLooking for participantsNCT07211139
What this trial is testing

Head and Neck Advanced Research for Multi-Omics and Optimized Immunotherapy

Who this might be right for
Head and Neck Cancer
Samsung Medical Center 30
Not applicableEnded earlyNCT04561453
What this trial is testing

Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer+5 more
University of Washington 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03376672
What this trial is testing

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Raija Silvennoinen 120
Testing effectiveness (Phase 2)Study completedNCT07102706
What this trial is testing

Phase I Trial of GR1803 Injection in Patients With RRMM

Who this might be right for
Multiple Myeloma (MM)
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 76
Next Page